Wellington Management Group LLP Sells 1,250 Shares of GRAIL, Inc. $GRAL

Wellington Management Group LLP reduced its stake in shares of GRAIL, Inc. (NASDAQ:GRAL) by 5.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,610 shares of the company’s stock after selling 1,250 shares during the quarter. Wellington Management Group LLP owned about 0.06% of GRAIL worth $552,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Raymond James Financial Inc. grew its stake in shares of GRAIL by 354.7% during the first quarter. Raymond James Financial Inc. now owns 121,169 shares of the company’s stock valued at $3,095,000 after purchasing an additional 94,518 shares during the last quarter. American Century Companies Inc. grew its holdings in GRAIL by 47.6% during the 1st quarter. American Century Companies Inc. now owns 17,702 shares of the company’s stock worth $452,000 after acquiring an additional 5,712 shares during the period. Aberdeen Group plc grew its holdings in GRAIL by 34.9% during the 1st quarter. Aberdeen Group plc now owns 284,735 shares of the company’s stock worth $7,272,000 after acquiring an additional 73,667 shares during the period. Legal Advantage Investments Inc. acquired a new stake in GRAIL during the 1st quarter worth $358,000. Finally, Caitong International Asset Management Co. Ltd grew its holdings in GRAIL by 211.7% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 4,145 shares of the company’s stock worth $106,000 after acquiring an additional 2,815 shares during the period.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lifted their target price on shares of GRAIL from $32.00 to $43.00 and gave the stock a “buy” rating in a report on Wednesday, May 14th. One research analyst has rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $31.50.

Insider Transactions at GRAIL

In other news, major shareholder Chun R. Ding sold 339,800 shares of GRAIL stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $49.53, for a total transaction of $16,830,294.00. Following the transaction, the insider directly owned 3,305,055 shares of the company’s stock, valued at $163,699,374.15. This trade represents a 9.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Aaron Freidin sold 8,000 shares of GRAIL stock in a transaction on Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total transaction of $311,440.00. Following the transaction, the chief financial officer directly owned 286,020 shares in the company, valued at approximately $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 361,694 shares of company stock valued at $17,780,266 over the last three months.

GRAIL Stock Down 3.9%

Shares of NASDAQ GRAL opened at $32.79 on Tuesday. The company’s fifty day moving average is $37.81 and its 200-day moving average is $36.08. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of -2.50 and a beta of 3.20. GRAIL, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99.

GRAIL (NASDAQ:GRAL) last announced its quarterly earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The firm had revenue of $35.54 million for the quarter, compared to the consensus estimate of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. On average, research analysts anticipate that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.